Extendicare Stock Analysis
EXE Stock | CAD 13.09 0.05 0.38% |
Extendicare is undervalued with Real Value of 14.51 and Hype Value of 13.04. The main objective of Extendicare stock analysis is to determine its intrinsic value, which is an estimate of what Extendicare is worth, separate from its market price. There are two main types of Extendicare's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Extendicare's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Extendicare's stock to identify patterns and trends that may indicate its future price movements.
The Extendicare stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Extendicare is usually not traded on Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day, Civic Holiday, Labour Day. Extendicare Stock trading window is adjusted to America/Toronto timezone.
Extendicare |
Extendicare Stock Analysis Notes
About 14.0% of the company shares are held by company insiders. The company last dividend was issued on the 31st of March 2025. Extendicare had 43:40 split on the 10th of November 2006. Extendicare Inc. provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. EXTENDICARE INC operates under Medical Care Facilities classification in Canada and is traded on Toronto Stock Exchange. It employs 22800 people. To learn more about Extendicare call MBA MD at 905 470 4000 or check out https://www.extendicare.com.Extendicare Investment Alerts
About 14.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: Extendicare Declares March 2025 Dividend - TipRanks |
Extendicare Largest EPS Surprises
Earnings surprises can significantly impact Extendicare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2018-11-08 | 2018-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2014-08-06 | 2014-06-30 | 0.1 | 0.09 | -0.01 | 10 | ||
2013-11-06 | 2013-09-30 | 0.06 | 0.04 | -0.02 | 33 |
Extendicare Thematic Classifications
In addition to having Extendicare stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
Extendicare Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Extendicare's market, we take the total number of its shares issued and multiply it by Extendicare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Extendicare Profitablity
Extendicare's profitability indicators refer to fundamental financial ratios that showcase Extendicare's ability to generate income relative to its revenue or operating costs. If, let's say, Extendicare is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Extendicare's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Extendicare's profitability requires more research than a typical breakdown of Extendicare's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.13 | 0.13 | |
Return On Capital Employed | 0.16 | 0.12 | |
Return On Assets | 0.10 | 0.11 | |
Return On Equity | 0.60 | 0.31 |
Management Efficiency
Extendicare has return on total asset (ROA) of 0.0998 % which means that it generated a profit of $0.0998 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7086 %, meaning that it generated $0.7086 on every $100 dollars invested by stockholders. Extendicare's management efficiency ratios could be used to measure how well Extendicare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Extendicare's Return On Tangible Assets are very stable compared to the past year. As of the 21st of March 2025, Return On Assets is likely to grow to 0.11, while Return On Capital Employed is likely to drop 0.12. At this time, Extendicare's Debt To Assets are very stable compared to the past year. As of the 21st of March 2025, Fixed Asset Turnover is likely to grow to 5.21, while Non Currrent Assets Other are likely to drop about 28 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.48 | 2.56 | |
Tangible Book Value Per Share | 0.04 | 0.04 | |
Enterprise Value Over EBITDA | 6.86 | 8.49 | |
Price Book Value Ratio | 7.20 | 7.56 | |
Enterprise Value Multiple | 6.86 | 8.49 | |
Price Fair Value | 7.20 | 7.56 | |
Enterprise Value | 1.1 B | 1.6 B |
Leadership effectiveness at Extendicare is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 21st of March, Extendicare shows the Coefficient Of Variation of 408.17, mean deviation of 1.21, and Downside Deviation of 1.16. Extendicare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Extendicare Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Extendicare middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Extendicare. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Extendicare Outstanding Bonds
Extendicare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Extendicare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Extendicare bonds can be classified according to their maturity, which is the date when Extendicare has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View |
Extendicare Predictive Daily Indicators
Extendicare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Extendicare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Extendicare Forecast Models
Extendicare's time-series forecasting models are one of many Extendicare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Extendicare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Extendicare Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Extendicare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Extendicare shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Extendicare. By using and applying Extendicare Stock analysis, traders can create a robust methodology for identifying Extendicare entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.07 | 0.07 | |
Operating Profit Margin | 0.06 | 0.08 | |
Net Profit Margin | 0.05 | 0.05 | |
Gross Profit Margin | 0.10 | 0.13 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Extendicare to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
All Next | Launch Module |
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.